Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01742780 · ClinicalTrials.gov registry record · NA

Evaluation of Various Methods Used to Identify the Proximal Humerus Intraosseous Vascular Access Site

A NA study, sponsored by Vidacare Corporation.

Completed
Registry status
NA
Development phase
60
Enrollment target

NCT01742780 is a NA study that has completed, run by Vidacare Corporation. The registered enrollment target is 60 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01742780, a NA study, has completed, sponsored by Vidacare Corporation.

COMPLETED
Registry status
NA
Development phase
60 participants
Enrollment target

Study Summary

The purpose of this study is to determine if there is one method of identifying the proximal humerus intraosseous vascular access site that is easier for clinicians to use, out of the 4 methods being evaluated.

Interventions

  • OTHER Intraosseous Vascular Access

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2012-12
Est. Completion 2012-12
Phase NA

Sponsor

Vidacare Corporation

11 total trials

What the Registry Record Tells You About NCT01742780

The ClinicalTrials.gov registry entry for NCT01742780 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vidacare Corporation, which has 11 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Intraosseous Vascular Access is the first listed.

NCT01742780 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01742780 about?

NCT01742780 is a clinical study titled "Evaluation of Various Methods Used to Identify the Proximal Humerus Intraosseous Vascular Access Site". The purpose of this study is to determine if there is one method of identifying the proximal humerus intraosseous vascular access site that is easier for clinicians to use, out of the 4 methods being evaluated.

What is the current status of trial NCT01742780?

This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2012-12. Estimated completion is 2012-12.

What interventions are being tested in trial NCT01742780?

The interventions under investigation include: Intraosseous Vascular Access (OTHER).

Who is sponsoring clinical trial NCT01742780?

This trial is sponsored by Vidacare Corporation, which has 11 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.